CL insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Noel Wallace Chairman, President & CEO, Director	4,892	$86.80	1.1%	455K	Sep 13, 2026	Sep 15, 2026
Stanley Sutula III Chief Financial Officer	1,385	$86.80	1.9%	71K	Sep 13, 2026	Sep 15, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin	922	$86.80	1.2%	76K	Sep 13, 2026	Sep 15, 2026
Sally Massey Chief People Officer	686	$86.80	n/a	n/a	Sep 13, 2026	Sep 15, 2026
John Hazlin Chief Growth Officer	499	$86.80	n/a	n/a	Sep 13, 2026	Sep 15, 2026
Betsy Fishbone CLO and Secretary	472	$86.80	2.1%	22K	Sep 13, 2026	Sep 15, 2026
Gregory Malcolm EVP and Controller	225	$86.80	n/a	n/a	Sep 13, 2026	Sep 15, 2026

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Noel Wallace Chairman, President & CEO, Director	3,516	$86.80	0.8%	460K	Sep 12, 2026	Sep 15, 2026
Stanley Sutula III Chief Financial Officer	927	$86.80	1.3%	72K	Sep 12, 2026	Sep 15, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin	618	$86.80	0.8%	77K	Sep 12, 2026	Sep 15, 2026
Sally Massey Chief People Officer	459	$86.80	n/a	n/a	Sep 12, 2026	Sep 15, 2026
John Hazlin Chief Growth Officer	439	$86.80	n/a	n/a	Sep 12, 2026	Sep 15, 2026
Betsy Fishbone CLO and Secretary	331	$86.80	1.4%	23K	Sep 12, 2026	Sep 15, 2026
Gregory Malcolm EVP and Controller	151	$86.80	n/a	n/a	Sep 12, 2026	Sep 15, 2026

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Noel Wallace Chairman, President & CEO, Director	4,071	$86.80	0.9%	463K	Sep 11, 2026	Sep 15, 2026
Stanley Sutula III Chief Financial Officer	1,197	$86.80	1.6%	73K	Sep 11, 2026	Sep 15, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin	684	$86.80	0.9%	78K	Sep 11, 2026	Sep 15, 2026
Sally Massey Chief People Officer	651	$86.80	n/a	n/a	Sep 11, 2026	Sep 15, 2026
John Hazlin Chief Growth Officer	649	$86.80	n/a	n/a	Sep 11, 2026	Sep 15, 2026
Shane Grant COO, Americas	622	$86.80	0.9%	70K	Sep 11, 2026	Sep 15, 2026
Betsy Fishbone CLO and Secretary	404	$86.80	1.7%	23K	Sep 11, 2026	Sep 15, 2026
Gregory Malcolm EVP and Controller	167	$86.80	n/a	n/a	Sep 11, 2026	Sep 15, 2026

What stands out

Noel Wallace sold $4.3M of stock with no disclosed trading plan. The filings don't state a reason.Largest such sale, Feb 4, 2026

Selling picked up in the last 90 days: officers and directors sold 336K shares, against an average of 91K per 90 days earlier in the period. Most of it was Noel Wallace (322K shares in the last 90 days) and Panagiotis Tsourapas (10K shares in the last 90 days); 0% of these sales were under disclosed plans.Noel Wallace: largest recent sale, Aug 5, 2026 · Panagiotis Tsourapas: largest recent sale, Aug 24, 2026

Percentages cover 15 of 20 officers and directors. 5 are left out

Left out: John Cahill, John Hazlin, Sally Massey and Gregory Malcolm (holdings couldn't be fully reconciled); Christopher Boerner (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

Noel Wallace

Chairman, President & CEO, Director

Sold $34.0M (plan status beside the amount). Exercised options and sold: 43% of the shares held or received (after tax withholding) during the period†. Stake: 446K → 487K. Why

$34.0M87% to cover taxes 13% no plan disclosed

Stanley Sutula III

Chief Financial Officer

Sold $9.2M (plan status beside the amount). Exercised options and sold: 55% of the shares held or received (after tax withholding) during the period†. Stake: 56K → 79K. Why

$9.2MTo cover taxes

Panagiotis Tsourapas

COO, CD, EMEA, APac, Skin

Sold $5.7M (plan status beside the amount). Exercised options and sold: 43% of the shares held or received (after tax withholding) during the period†. Stake: 76K → 81K. Why

$5.7M84% to cover taxes 16% no plan disclosed

Sally Massey

Chief People Officer

Sold $2.4M (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$2.4M64% to cover taxes 36% no plan disclosed

Jennifer Daniels

CLO and Secretary

Sold $2.1M (plan status beside the amount). Exercised options and sold: 19% of the shares held or received (after tax withholding) during the period†. Stake: 78K → 92K. Why

$2.1MTo cover taxes

All 8 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Colgate-Palmolive CEO selling stock?

Yes. Noel Wallace sold 368K shares ($34.0M) in the past 12 months, none of it under a trading plan disclosed in the filings.

Why are Colgate-Palmolive insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings, 88% were to cover taxes and 12% had no disclosed plan. A trading plan schedules sales in advance.

Are any Colgate-Palmolive insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Colgate-Palmolive insiders sell?

About 33% of the shares they held or received (after tax withholding) during the period. The usual measure, against starting holdings alone, can't be used here because most of the shares sold arrived during the period, through vesting or option exercises. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold8 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Noel Wallace Chairman, President & CEO, Director	$34.0M 368K shares	43%† Exercised options and sold. Stake: 446K → 487K i † Noel Wallace exercised options and sold those shares, so this is shares sold as a share of the 446K held at the start plus the 488K received, less 82K withheld by the company for taxes.	87% to cover taxes 13% no plan disclosed
Stanley Sutula III Chief Financial Officer	$9.2M 98K shares	55%† Exercised options and sold. Stake: 56K → 79K i † Stanley Sutula III exercised options and sold those shares, so this is shares sold as a share of the 56K held at the start plus the 145K received, less 24K withheld by the company for taxes.	To cover taxes
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin	$5.7M 60K shares	43%† Exercised options and sold. Stake: 76K → 81K i † Panagiotis Tsourapas exercised options and sold those shares, so this is shares sold as a share of the 76K held at the start plus the 80K received, less 16K withheld by the company for taxes.	84% to cover taxes 16% no plan disclosed
Sally Massey Chief People Officer	$2.4M 26K shares	i No percentage: holdings couldn't be fully reconciled.	64% to cover taxes 36% no plan disclosed
Jennifer Daniels CLO and Secretary	$2.1M 22K shares	19%† Exercised options and sold. Stake: 78K → 92K i † Jennifer Daniels exercised options and sold those shares, so this is shares sold as a share of the 78K held at the start plus the 48K received, less 13K withheld by the company for taxes.	To cover taxes
John Hazlin Chief Growth Officer	$2.0M 21K shares	i No percentage: holdings couldn't be fully reconciled.	To cover taxes
Gregory Malcolm EVP and Controller	$1.4M 15K shares	i No percentage: holdings couldn't be fully reconciled.	86% to cover taxes 14% no plan disclosed
John Cahill Director	$389K 4.2K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed

The full ownership picture16 of 20 insiders fully reconciled · 20 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Noel Wallace

Minor difference of 2,540 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 574 shares from stock units or awards that vested. 574 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Chairman, President & CEO, Director

446K

−368K

487K

not meaningful

Vesting, gifts, unvested awards and holding lines for Noel Wallace

+322Kshares vested or exercised

0gifted (net of own trusts)

−82Kwithheld by the company for taxes

none reportedunvested awards, start → end

574 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Filing 1 Filing 2
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	339,715	379,700
Issuer's 401(k) Plan Trustee	Common Stock	53,560	54,868
Spouse Trust	Common Stock	52,000	52,000
Trust	Common Stock	335	335

Additional holdings last reported May 8, 2009, not confirmed since: 3,232 shares. Not included in any total or percentage on this page.

Issuer's 401(k) Plan Trustee, Series B Convertible Preference Stock: 3,232 shares, last reported May 8, 2009

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
145,696	$106.34	Sep 12, 2032	$0
196,047	$84.06	Sep 11, 2033	$1.6M
205,197	$87.02	Sep 16, 2036	$1.0M

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 2,540 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 574 shares from stock units or awards that vested.

Shane Grant

Minor difference of 1,998 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 1,998 shares from stock units or awards that vested. 1,998 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change.

COO, Americas

94K

80K

no sales

Vesting, gifts, unvested awards and holding lines for Shane Grant

0shares vested or exercised

0gifted (net of own trusts)

−24Kwithheld by the company for taxes

none reportedunvested awards, start → end

1,998 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Filing 1 Filing 2

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	94,119	79,503

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
24,712	$84.06	Sep 11, 2033	$197K
50,902	$87.02	Sep 16, 2036	$256K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 1,998 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 1,998 shares from stock units or awards that vested.

Jennifer Daniels

Minor difference of 131 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 47 shares from stock units or awards that vested. 47 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change.

CLO and Secretary

78K

−22K

92K

not meaningful

Vesting, gifts, unvested awards and holding lines for Jennifer Daniels

+22Kshares vested or exercised

0gifted (net of own trusts)

−13Kwithheld by the company for taxes

none reportedunvested awards, start → end

47 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Filing

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	76,559	89,844
Issuer's 401(k) Plan Trustee	Common Stock	1,813	1,837

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
25,563	$106.34	Sep 12, 2032	$0
31,796	$84.06	Sep 11, 2033	$254K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 131 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 47 shares from stock units or awards that vested.

Panagiotis Tsourapas

Minor difference of 325 shares. Difference is under 0.5% of holdings. New Form 3 filed 2019-08-02; earlier filings set aside.

COO, CD, EMEA, APac, Skin

76K

−60K

81K

not meaningful

Vesting, gifts, unvested awards and holding lines for Panagiotis Tsourapas

+50Kshares vested or exercised

0gifted (net of own trusts)

−16Kwithheld by the company for taxes

none reportedunvested awards, start → end

New Form 3 filed 2019-08-02; earlier filings set aside.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	10,575	11,447
Trust	Common Stock	60,745	64,901
Issuer's 401(k) Plan Trustee	Common Stock	4,509	4,619

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
19,938	$76.41	Sep 10, 2028	$312K
25,563	$106.34	Sep 12, 2032	$0
32,949	$84.06	Sep 11, 2033	$263K
31,814	$87.02	Sep 16, 2036	$160K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 325 shares. Difference is under 0.5% of holdings.

Prabha Parameswaran

Vice Chair

64K

no sales

Vesting, gifts, unvested awards and holding lines for Prabha Parameswaran

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	11,018	11,018
Trust	Common Stock	46,810	46,810
Issuer's 401(k) Plan Trustee	Common Stock	5,955	5,955

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
31,954	$106.34	Sep 12, 2032	$0
31,796	$84.06	Sep 11, 2033	$254K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

John Cahill

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -1,402 shares on May 11, 2026 (Direct). See the filing Sales and other transactions for John Cahill are complete.

Director

n/a

−4.2K

n/a

Vesting, gifts, unvested awards and holding lines for John Cahill

+4.2Kshares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -1,402 shares on May 11, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	27,543	28,373
Trust	Common Stock	34,338	36,357

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Stanley Sutula III

Minor difference of 357 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 251 shares from stock units or awards that vested. 251 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change.

Chief Financial Officer

56K

−98K

79K

not meaningful

Vesting, gifts, unvested awards and holding lines for Stanley Sutula III

+98Kshares vested or exercised

0gifted (net of own trusts)

−24Kwithheld by the company for taxes

none reportedunvested awards, start → end

251 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Filing 1 Filing 2

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	55,596	79,029
Issuer's 401(k) Plan Trustee	Common Stock	324	331

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
38,411	$106.34	Sep 12, 2032	$0
57,661	$84.06	Sep 11, 2033	$461K
55,674	$87.02	Sep 16, 2036	$280K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 357 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 251 shares from stock units or awards that vested.

John Bilbrey

Minor difference of 889 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

41K

45K

no sales

Vesting, gifts, unvested awards and holding lines for John Bilbrey

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	36,658	40,725
Trust	Common Stock	4,719	4,719

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 889 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Lorrie Norrington

Minor difference of 954 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

39K

43K

no sales

Vesting, gifts, unvested awards and holding lines for Lorrie Norrington

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	39,061	43,310

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 954 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Betsy Fishbone

Minor difference of 29 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 29 shares from stock units or awards that vested. 29 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Started reporting during the period; starting holdings are from the Form 3.

CLO and Secretary

23K

24K

no sales

Vesting, gifts, unvested awards and holding lines for Betsy Fishbone

0shares vested or exercised

0gifted (net of own trusts)

−1.2Kwithheld by the company for taxes

none reportedunvested awards, start → end

29 shares arrived when stock units or awards vested, by the footnote; no acquisition was reported, so the amount is derived from the balance change. Filing
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	15,021	16,050
Issuer's 401(k) Plan Trustee	Common Stock	8,336	8,336
Family Member	Common Stock	50	50

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
9,944	$72.83	Sep 13, 2031	$191K
19,012	$77.04	Sep 10, 2029	$285K
16,612	$78.03	Sep 9, 2030	$233K
9,392	$84.06	Sep 11, 2033	$75K
6,848	$106.34	Sep 12, 2032	$0
15,271	$87.02	Sep 16, 2036	$77K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 29 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 29 shares from stock units or awards that vested.

John Hazlin

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +172 shares on Dec 3, 2025 (Direct). See the filing Sales and other transactions for John Hazlin are complete.

Chief Growth Officer

n/a

−21K

n/a

Vesting, gifts, unvested awards and holding lines for John Hazlin

+21Kshares vested or exercised

0gifted (net of own trusts)

−7.9Kwithheld by the company for taxes

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +172 shares on Dec 3, 2025 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	17,629	27,021
Issuer's 401(k) Plan Trustee	Common Stock	5,382	5,513

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
19,342	$72.83	Sep 13, 2031	$372K
23,376	$77.04	Sep 10, 2029	$351K
22,944	$78.03	Sep 9, 2030	$322K
16,689	$106.34	Sep 12, 2032	$0
28,007	$84.06	Sep 11, 2033	$224K
27,042	$87.02	Sep 16, 2036	$136K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Sally Massey

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +54 shares on Nov 21, 2025 (Issuer's 401(k) Plan Trustee). See the filing Sales and other transactions for Sally Massey are complete.

Chief People Officer

n/a

−26K

n/a

Vesting, gifts, unvested awards and holding lines for Sally Massey

+16Kshares vested or exercised

0gifted (net of own trusts)

−10Kwithheld by the company for taxes

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +54 shares on Nov 21, 2025 (Issuer's 401(k) Plan Trustee). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	14,946	15,397
Issuer's 401(k) Plan Trustee	Common Stock	8,004	8,199

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,689	$106.34	Sep 12, 2032	$0
23,888	$84.06	Sep 11, 2033	$191K
23,065	$87.02	Sep 16, 2036	$116K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Martin Harris

Minor difference of 160 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

23K

25K

no sales

Vesting, gifts, unvested awards and holding lines for Martin Harris

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	22,801	24,517

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 160 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Gregory Malcolm

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +57 shares on Feb 6, 2026 (Issuer's 401(k) Plan Trustee). See the filing Sales and other transactions for Gregory Malcolm are complete.

EVP and Controller

n/a

−15K

n/a

Vesting, gifts, unvested awards and holding lines for Gregory Malcolm

+13Kshares vested or exercised

0gifted (net of own trusts)

−2.8Kwithheld by the company for taxes

none reportedunvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +57 shares on Feb 6, 2026 (Issuer's 401(k) Plan Trustee). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	11,905	14,162
Issuer's 401(k) Plan Trustee	Common Stock	8,445	8,650

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,226	$106.34	Sep 12, 2032	$0
7,743	$84.06	Sep 11, 2033	$62K
7,477	$87.02	Sep 16, 2036	$38K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Lisa Edwards

Minor difference of 61 shares. Difference is under 0.5% of holdings.

Director

16K

18K

no sales

Vesting, gifts, unvested awards and holding lines for Lisa Edwards

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	16,046	18,182

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,077	$69.38	May 11, 2028	$47K
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 61 shares. Difference is under 0.5% of holdings.

Martina Hundmejean

Minor difference of 257 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

14K

16K

no sales

Vesting, gifts, unvested awards and holding lines for Martina Hundmejean

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	13,874	16,206

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 257 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Kimberly Nelson

Minor difference of 199 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

12K

14K

no sales

Vesting, gifts, unvested awards and holding lines for Kimberly Nelson

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	9,360	11,634
Trust	Common Stock	1,799	1,799
Family Trust	Common Stock	575	575
Spouse	Common Stock	215	215

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 199 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Steven Cahillane

Director

6.8K

no sales

Vesting, gifts, unvested awards and holding lines for Steven Cahillane

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	6,754	6,754

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,201	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Brian Newman

Minor difference of 47 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

5.1K

8.1K

no sales

Vesting, gifts, unvested awards and holding lines for Brian Newman

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	5,065	8,058
Family Trust	Common Stock	36	36

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,834	$94.46	May 13, 2032	$0
2,272	$89.14	May 12, 2033	$7K
2,424	$86.74	May 11, 2034	$13K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

Reconciliation: minor difference of 47 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Christopher Boerner

Director

1.4K

no sales

Vesting, gifts, unvested awards and holding lines for Christopher Boerner

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	1,383

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,020	$86.74	May 11, 2034	$11K

Estimate: options held × ($92.05 − strike price), using the most recent insider trade price on Form 4 (Aug 24, 2026), not a market close.

16 of 20 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (3 exactly, 13 with a minor or footnoted difference). For 4 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 15 of 20 officers and directors. Left out: John Cahill, John Hazlin, Sally Massey and Gregory Malcolm (holdings couldn't be fully reconciled); Christopher Boerner (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$57.1M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $57.1M across 613,346 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $57.1M

No plan disclosed · $6.6M

Sales with no 10b5-1 plan and no tax reference in the filing. $4.3M of it is Noel Wallace. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Noel Wallace, Feb 4, 2026

Taxes

$50.5M of sales (88.4%) cite tax obligations in their footnotes. Separately, 179,650 shares ($17.0M) were withheld by the company for taxes, which isn't a market sale. Example: Noel Wallace, Aug 5, 2026

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Noel Wallace Chairman, President & CEO, Director	368K	$34.0M	0%	59%	Feb 4, 2026 to Aug 5, 2026
Stanley Sutula III Chief Financial Officer	98K	$9.2M	0%	16%	Feb 4, 2026 to Feb 4, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin	60K	$5.7M	0%	10%	Feb 11, 2026 to Aug 24, 2026
Sally Massey Chief People Officer	26K	$2.4M	0%	4%	Nov 21, 2025 to May 7, 2026
Jennifer Daniels CLO and Secretary	22K	$2.1M	0%	4%	Feb 4, 2026 to Feb 4, 2026
John Hazlin Chief Growth Officer	21K	$2.0M	0%	3%	Feb 10, 2026 to Feb 10, 2026
Gregory Malcolm EVP and Controller	15K	$1.4M	0%	2%	Feb 6, 2026 to May 15, 2026
John Cahill Director	4.2K	$389K	0%	0.7%	Aug 6, 2026 to Aug 6, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$100K	$0	$0	$100K
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$25.1M	$0	$20.8M	$4.3M
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$955K	$0	$0	$955K
Jun 2026	$0	$0	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$31.0M	$0	$29.7M	$1.3M
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 8 insiders sold; the average is 11 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	613K	8	$57.1M
Oct 9, 2025 1 year earlier	160K	5	$15.0M
Oct 9, 2024 2 years earlier	588K	12	$51.9M
Oct 10, 2023 3 years earlier	399K	13	$31.3M
Oct 10, 2022 4 years earlier	711K	14	$56.4M
Oct 10, 2021 5 years earlier	497K	13	$41.4M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty4 insiders whose holdings couldn't be fully reconciled

John Cahill: holdings couldn't be fully reconciled (difference of 774 shares). Balance changed without a matching transaction, and the footnote does not state the amount: -1,402 shares on May 11, 2026 (Direct). Filing, May 11, 2026

Footnote: "Annual director stock grant under the issuer's incentive compensation plan."

John Hazlin: holdings couldn't be fully reconciled (difference of 672 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +172 shares on Dec 3, 2025 (Direct). Filing, Dec 3, 2025

Footnote: "Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding."

Sally Massey: holdings couldn't be fully reconciled (difference of 346 shares). Balance changed with no matching transaction and no footnote: +54 shares on Nov 21, 2025 (Issuer's 401(k) Plan Trustee). Filing, Nov 21, 2025

Gregory Malcolm: holdings couldn't be fully reconciled (difference of 257 shares). Balance changed with no matching transaction and no footnote: +57 shares on Feb 6, 2026 (Issuer's 401(k) Plan Trustee). Filing, Feb 6, 2026

Noel Wallace: minor difference of 2,540 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 574 shares from stock units or awards that vested.

Shane Grant: minor difference of 1,998 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 1,998 shares from stock units or awards that vested.

Jennifer Daniels: minor difference of 131 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 47 shares from stock units or awards that vested.

Panagiotis Tsourapas: minor difference of 325 shares. Difference is under 0.5% of holdings.

Stanley Sutula III: minor difference of 357 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 251 shares from stock units or awards that vested.

John Bilbrey: minor difference of 889 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Lorrie Norrington: minor difference of 954 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Betsy Fishbone: minor difference of 29 shares. Footnotes say what happened but give no amount, so the amounts are derived from the balance changes: 29 shares from stock units or awards that vested.

Martin Harris: minor difference of 160 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Lisa Edwards: minor difference of 61 shares. Difference is under 0.5% of holdings.

Martina Hundmejean: minor difference of 257 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Kimberly Nelson: minor difference of 199 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Brian Newman: minor difference of 47 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Inferred rename: "401(k) Plan" is treated as the same holder as "401(k) Plan Trustee", because the old name was never reported again and the new one opened with the same balance (21,624 shares). Old name, new name

Inferred rename: "401(k) Plan Trustee" is treated as the same holder as "issuer's 401(k) plan trustee", because the old name was never reported again and the new one opened with the same balance (21,624 shares). Old name, new name

Inferred rename: "401(k) Plan Trustee" is treated as the same holder as "issuer's 401(k) Plan Trustee", because the old name was never reported again and the new one opened with the same balance (0 shares). Old name, new name

Inferred rename: "GRAT" is treated as the same holder as "2012 GRAT", because the old name was never reported again and the new one opened with the same balance (95,282 shares). Old name, new name

Inferred rename: "Mr" is treated as the same holder as "a family limited liability company owned by Mr", because the old name was never reported again and the new one opened with the same balance (771,036 shares). Old name, new name

Inferred rename: "401(k) Plan trustee" is treated as the same holder as "issuer's 401(k) Plan Trustee", because the old name was never reported again and the new one opened with the same balance (0 shares). Old name, new name

Inferred rename: "In Trust" is treated as the same holder as "Trust", because the old name was never reported again and the new one opened with the same balance (0 shares). Old name, new name

Inferred rename: "Hill's United Kingdom Stock Savings Plan Trustee" is treated as the same holder as "Hill's U.K. Stock Savings Plan", because the old name was never reported again and the new one opened with the same balance (416 shares). Old name, new name

Inferred typo: the share class "Comon Stock" is treated as the same class as "Common Stock" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Howard Wentz Jr., 109,018 shares): old title, new title

Inferred typo: the share class "Cmmon Stock" is treated as the same class as "Common Stock" on 2 holding lines, because the two spellings are nearly identical and each balance carried over exactly. Example (David Johnson, 113,158 shares): old title, new title

Inferred typo: the share class "Common Stoxk" is treated as the same class as "Common Stock" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Richard Kogan, 92,962 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology3,050 filings from SEC EDGAR, and how we read them

All 3,050 Forms 3, 4 and 5 filed for Colgate-Palmolive (SEC CIK 21665) from Jul 10, 2003 to Oct 2, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages.

Probable 2-for-1 stock split on or before May 21, 2013 (first filing that shows post-split balances). Splits aren't reported as transactions; 9 holding lines changed by exactly this ratio, so earlier share counts are restated.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (61)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
John Kooyman	Sep 16, 2024	15,834 shares, last reported balance as of Sep 13, 2024
Stephen Sadove	May 17, 2023	36,377 shares, last reported balance as of May 15, 2023
Michael Polk	May 17, 2023	25,803 shares, last reported balance as of May 15, 2023
Patricia Verduin	Nov 9, 2022	67,785 shares, last reported balance as of Nov 7, 2022
Philip Shotts	May 18, 2022	99,783 shares, last reported balance as of May 16, 2022
Helene Gayle	Apr 5, 2021	40,752 shares, last reported balance as of Apr 1, 2021
Henning Jakobsen	Nov 6, 2020	10,341 shares, last reported balance as of Nov 4, 2020
John Huston	Sep 14, 2020	89,946 shares, last reported balance as of Aug 12, 2020
Daniel Marsili	Sep 14, 2020	73,580 shares, last reported balance as of Mar 16, 2020
Ian Cook	Apr 1, 2020	1,613,582 shares, last reported balance as of Mar 30, 2020
Justin Skala	Aug 1, 2019	205,873 shares, last reported balance as of May 20, 2019
Charles Bancroft	May 15, 2019	8,114 shares, last reported balance as of May 13, 2019
Dennis Hickey	Feb 21, 2019	530,134 shares, last reported balance as of Feb 19, 2019
Ellen Hancock	Feb 1, 2019	208,018 shares, last reported balance as of Aug 27, 2018
Franck Moison	Dec 10, 2018	233,316 shares, last reported balance as of Dec 6, 2018
Mukul Deoras	Sep 17, 2018	45,917 shares, last reported balance as of Sep 13, 2018
Victoria Dolan	Feb 22, 2018	50,971 shares, last reported balance as of Feb 20, 2018
Richard Kogan	May 10, 2017	65,065 shares, last reported balance as of May 8, 2017
Delia Thompson	Feb 27, 2017	169,957 shares, last reported balance as of Feb 23, 2017
Fabian Garcia	Mar 9, 2016	146,389 shares, last reported balance as of Mar 7, 2016
Delano Lewis	Feb 9, 2016	17,920 shares, last reported balance as of Feb 5, 2016
Pedro Reinhard	Feb 9, 2016	50,329 shares, last reported balance as of Feb 5, 2016
Nigel Burton	Jun 15, 2015	49,702 shares, last reported balance as of Jun 11, 2015
Andrew Hendry	Mar 11, 2015	235,104 shares, last reported balance as of Mar 9, 2015
Joseph Jimenez	Jan 5, 2015	22,950 shares, last reported balance as of Jan 2, 2015
Nikesh Arora	Jul 3, 2014	14,831 shares, last reported balance as of Jul 3, 2014
Stephen Fogarty	May 9, 2014	56,528 shares, last reported balance as of May 7, 2014
Ronald Martin	May 6, 2014	22,611 shares, last reported balance as of May 2, 2014
Francis Williamson	May 6, 2014	276,191 shares, last reported balance as of May 2, 2014
Alec de Guillenchmidt	Feb 27, 2014	97,563 shares, last reported balance as of Feb 25, 2014
Elaine Paik	Feb 27, 2014	29,304 shares, last reported balance as of Feb 25, 2014
Thomas Greene Jr.	Feb 27, 2014	29,837 shares, last reported balance as of Feb 25, 2014
Michael Corbo	Feb 27, 2014	81,783 shares, last reported balance as of Feb 25, 2014
Peter Brons-Poulsen	Feb 27, 2014	61,618 shares, last reported balance as of Feb 25, 2014
Hector Erezuma	Dec 9, 2013	110,210 shares, last reported balance as of Dec 5, 2013
Rosemary Nelson	Dec 9, 2013	36,763 shares, last reported balance as of Dec 5, 2013
Katherine Ramundo	Sep 17, 2012	27,762 shares, last reported balance as of Sep 11, 2012
Gregory Woodson	Mar 12, 2012	197,188 shares, last reported balance as of Mar 8, 2012
Neil Thompson	Mar 12, 2012	63,014 shares, last reported balance as of Mar 8, 2012
Michael Tangney	Dec 5, 2011	1,129,982 shares, last reported balance as of Dec 1, 2011
Derrick Samuel	Dec 5, 2011	126,835 shares, last reported balance as of Dec 1, 2011
Stephen Patrick	Feb 28, 2011	337,062 shares, last reported balance as of Feb 28, 2011
Nina Gillman	Dec 30, 2010	61,529 shares, last reported balance as of Dec 29, 2010
David Groener	Dec 30, 2010	106,850 shares, last reported balance as of Dec 29, 2010
Jill Conway	Feb 19, 2010	91,430 shares, last reported balance as of Feb 2, 2010
David Johnson	Feb 19, 2010	124,774 shares, last reported balance as of Feb 2, 2010
Edward Filusch	Dec 7, 2009	42,114 shares, last reported balance as of Dec 3, 2009
Edmund Toben	Dec 7, 2009	176,756 shares, last reported balance as of Dec 3, 2009
Robert Wheeler	Mar 4, 2009	508,126 shares, last reported balance as of Mar 3, 2009
Reuben Mark	Feb 6, 2009	14,899,388 shares, last reported balance as of Dec 11, 2008
Seamus McBride	May 20, 2008	114,586 shares, last reported balance as of May 19, 2008
Philip Berry	May 7, 2008	36,888 shares, last reported balance as of May 5, 2008
Javier Teruel	Mar 12, 2007	598,284 shares, last reported balance as of Mar 8, 2007
Howard Wentz Jr.	Feb 22, 2007	111,724 shares, last reported balance as of Feb 2, 2007
Ronald Ferguson	Nov 10, 2005	199,298 shares, last reported balance as of Nov 10, 2005
Steven Belasco	Sep 12, 2005	136,764 shares, last reported balance as of Sep 8, 2005
William Shanahan	Sep 12, 2005	290,396 shares, last reported balance as of Sep 8, 2005
Elizabeth Monrad	May 6, 2005	16,502 shares, last reported balance as of Feb 1, 2005
Robert Joy	Mar 14, 2005	74,446 shares, last reported balance as of Mar 10, 2005
Lois Juliber	Mar 14, 2005	932,308 shares, last reported balance as of Mar 10, 2005
Carlos Gutierrez	Feb 19, 2004	15,808 shares, last reported balance as of Feb 6, 2004

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Colgate-Palmolive insiders sold $57.1M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Colgate-Palmolive CEO selling stock?

Why are Colgate-Palmolive insiders selling?

Are any Colgate-Palmolive insiders buying?

How much of their stake did Colgate-Palmolive insiders sell?

The evidence

No plan disclosed · $6.6M

Taxes

Sales by month